Title : Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinib.

Pub. Date : 2006 Sep

PMID : 16406018






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Because of the availability of a superior targeted drug (imatinib), it is of importance to screen for FIP1L1/PDGFRalpha in suspected CEL with or without co-existing SM. Imatinib Mesylate factor interacting with PAPOLA and CPSF1 Homo sapiens